HealthTronics OssaTron Market Expands 10-Fold With Tennis Elbow Indication
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of HealthTronics' OssaTron high-energy shockwave device for "tennis-elbow" treatment gives the company access to the U.S. general orthopedics market, which includes about 20,000 practices, according to the firm
You may also be interested in...
Siemens Sonocur Swings Approval: Low Energy Level Touted For Tennis Elbow
Siemens is highlighting a statistically significant pain reduction rate (50%) in nearly two-thirds (64%) of patients using the Sonocur Basic low-energy extracorporeal shockwave therapy system for lateral epicondylitis, or "tennis elbow.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.